The microfluidic devices market is projected to grow at a CAGR of 22.36% from 2026 to 2035, rising from USD 29.76 billion in 2026 to USD 182.98 billion by 2035 (2025 base USD 24.32 billion). Growth is driven by demand for point-of-care testing, applications in proteomics, genomics and personalized medicine, lab-on-a-chip advances, and integration with biosensors and AI.
Market Snapshot
- Revenue, 2026: 29.76 Billion
- Forecast, 2035: 182.98 Billion
- CAGR, 2026-2035: 22.36%
- Report Coverage: Global
Key Companies
- uFluidix
- Fluidigm
- PerkinElmer
- Blacktrace Holdings Ltd. (Dolomite Microfluidic)
- Micronit
- BioFluidix GmbH
- Fluigent
- ALine Inc.
- Philips
- Others
About Healthcare Foresights
Healthcare Foresights provides market research and consulting across the healthcare and life sciences industry, combining industry research, analytical expertise and technology-enabled solutions to help companies, investors and decision-makers identify opportunities and drive growth. For the full report, customization or a sample, contact our team.